ISRG Intuitive Surgical

XNGS Sideways Alert

Health Care

· How we analyze

About the company

Intuitive Surgical is a US medical technology company and pioneer of surgical robots. With the da Vinci system, surgeons perform minimally invasive procedures, for example in urology, gynecology and general surgery. Revenue also comes from instruments and service per procedure. As of Oct 11, 2026

Fact sheet (from the annual report) Orthopedic and surgical supplies · Sunnyvale, USA

Intuitive Surgical offers robotic-assisted systems, instruments and accessories, training and customer service, connected through digital offerings. These include the da Vinci surgical system and Ion for bronchoscopy, for example for biopsy of small lung nodules. A network of field service engineers handles installation, repair, maintenance, round-the-clock technical support and predictive monitoring of the systems. In addition, there are digital services such as the My Intuitive app, the My Intuitive+ subscription and data analytics for hospitals. The systems are used, for example, in gallbladder removal, hernia surgery and colorectal procedures.

Automatically summarized from SEC annual report (10-K, filed Feb 3, 2026) (website of the US Securities and Exchange Commission) · reviewed Oct 14, 2026

Price performance at a glance

Last 30 trading days
  • Today −1.3%
  • 7 days +1.8%
  • 30 days +10.0%
  • 1 year −19.1%
Day range (last trading day)
−0.5%Price at 26% of the range+1.3%
52-week range
−26.3%Price at 43% of the range+35.4%
Distance from the all-time high
−27.6%

Our own calculation from the exchange’s daily candles, as of Oct 27, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.

Pullback in trend · Analysis method

The price of ISRG is currently in no zone of this method. The check runs daily after the market close.

Whether a price will soon reach a zone, you see from Watcher. Plans and pricing

How the zone is formed

What is this? In an intact uptrend (price above the 200-day line, 50-day line rising), the price pulls back to the 50-day line after a rise and closes back above it.

Buy zone: around the 50-day line (± 0.5 ATR). Stop: 1.5 ATR below it. Target 1: the last high, Target 2: 2 ATR above it.

The pattern is valid for at most 15 trading days and expires if the price falls below the stop. This is a calculated analysis, not a forecast and not a call to buy. Risk notice and investment advice

Load chart from TradingView

This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.

Symbol on TradingView: NASDAQ:ISRG

Fundamental analysis

Intuitive Surgical · Sector Health Care · amounts in USD

Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 3, 2026.

In short

  • Light green: Revenue grew over 5 years (+18.2% per year), at least as fast as the sector median.
  • Light green: Net income (total) grew over 5 years (+21.9% per year), at least as fast as the sector median; per share +21.8% per year.
  • Light green: Net margin 28.4%, above the sector median (12.9%).
  • Light green: Profit in each of the last 10 fiscal years.

Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.

RevenueNet income Net margin (below) in USD
  1. Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 2.7B USD · Net income 735.9M USD · Net margin 27.2%
  2. Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 3.1B USD · Net income 660.0M USD · Net margin 21.0%
  3. Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 3.7B USD · Net income 1.1B USD · Net margin 30.3%
  4. Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 4.5B USD · Net income 1.4B USD · Net margin 30.8%
  5. Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 4.4B USD · Net income 1.1B USD · Net margin 24.3%
  6. Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 5.7B USD · Net income 1.7B USD · Net margin 29.9%
  7. Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 6.2B USD · Net income 1.3B USD · Net margin 21.3%
  8. Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 7.1B USD · Net income 1.8B USD · Net margin 25.2%
  9. Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 8.4B USD · Net income 2.3B USD · Net margin 27.8%
  10. Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 10.1B USD · Net income 2.9B USD · Net margin 28.4%

Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 10.1B USD · Net income 2.9B USD · Net margin 28.4%

Key figures with traffic lights

Each light follows a simple, disclosed rule. The comparison is with the sector median of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).

Revenue growth

Light green: above sector

+18.2% per year, last 5 years

Sector Health Care: median +7.8% (60 symbols)

What does this mean? Revenue: over 5 years it grew by 18.2% per year on average – at least as fast as the median company in the sector (+7.8%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net income (total)

Light green: above sector

+21.9% per year, last 5 years

Sector Health Care: median +7.5% (46 symbols)

per share: +21.8% per year (5 years, split-adjusted)

What does this mean? Total net income: over 5 years it grew by 21.9% per year on average – at least as fast as the median company in the sector (+7.5%).

Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.

Net margin

Light green: above sector

28.4% last fiscal year

Sector Health Care: median 12.9% (63 symbols)

What does this mean? Of every 100 USD in revenue, 28.38 USD remained as profit – at least as much as the median company in the sector (12.9%). Five years ago the margin was 24.3%.

Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.

Debt / equity

Light gray: not available

– latest balance sheet

Sector Health Care: median 0.66 (40 symbols)

What does this mean? No usable figure: reported financial debt or positive equity for the same balance sheet date is missing.

Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.

Payout ratio

Light gray: none found

– Dividend / earnings per share

Sector Health Care: median 28% (31 symbols)

What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.

Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.

Profitable years

Light green: profit every year

10 of 10 fiscal years with a profit

What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.

Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).

Last fiscal year and 13F

Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
10.1B USD
Revenue vs. prior year
+20.5%
Net income (FY)
2.9B USD
Net income vs. prior year
+23.0%
EPS (FY)
7.87 USD
13F funds with a position
3 of 9
Funds vs. prior quarter
±0
Shares held vs. prior quarter
−34.0%
Fiscal year to Dec 31, 2025 · 10-K filed Feb 3, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term). 13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
YearEndRevenueNet income MarginEarnings per shareDividend per sharePayout
2025Dec 31, 2025 10.1B2.9B 28.4% 7.87 – –
2024Dec 31, 2024 8.4B2.3B 27.8% 6.42 – –
2023Dec 31, 2023 7.1B1.8B 25.2% 5.03 – –
2022Dec 31, 2022 6.2B1.3B 21.3% 3.65 – –
2021Dec 31, 2021 5.7B1.7B 29.9% 4.66 – –
2020Dec 31, 2020 4.4B1.1B 24.3% 2.94 – –
2019Dec 31, 2019 4.5B1.4B 30.8% 3.85 – –
2018Dec 31, 2018 3.7B1.1B 30.3% 3.16 – –
2017Dec 31, 2017 3.1B660.0M 21.0% 1.89 – –
2016Dec 31, 2016 2.7B735.9M 27.2% 2.08 – –
Quarters (amounts in USD, per share in USD)
QuarterEndRevenueNet income MarginEarnings per shareDividend per sharePayout
Q3/26Sep 30, 2026 3.0B522.8M 17.1% 1.49 – –
Q2/26Jun 30, 2026 2.9B818.1M 28.3% 2.29 – –
Q1/26Mar 31, 2026 2.8B821.5M 29.6% 2.28 – –
Q4/25*Dec 31, 2025 2.9B794.8M 27.7% – – –
Q3/25Sep 30, 2025 2.5B704.4M 28.1% 1.95 – –
Q2/25Jun 30, 2025 2.4B658.4M 27.0% 1.81 – –
Q1/25Mar 31, 2025 2.3B698.4M 31.0% 1.92 – –
Q4/24*Dec 31, 2024 2.4B685.7M 28.4% – – –
Q3/24Sep 30, 2024 2.0B565.1M 27.7% 1.56 – –
Q2/24Jun 30, 2024 2.0B526.9M 26.2% 1.46 – –
Q1/24Mar 31, 2024 1.9B544.9M 28.8% 1.51 – –
Q4/23*Dec 31, 2023 1.9B606.2M 31.4% – – –

* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.

How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year over 5 years (otherwise 3 years). Per-share values adjusted for stock split 3:1 (between Jul 21, 2017 and Oct 20, 2017), 3:1 (between Jul 21, 2021 and Oct 20, 2021). Quarters are labeled by the calendar quarter in which they end.

Insiders

All insider transactions
Insider purchases and sales on the market over 3, 6 and 12 months
PeriodPurchasesSalesNet
3 months $00 people $16.9M7 people −$16.9M
6 months $00 people $20.0M8 people −$20.0M
12 months $00 people $70.9M11 people −$70.9M

Latest transactions

  • Oct 23, 2026 Widman Fredrik Officer Open-market sale · 10b5-1 plan 4,047 shares · $1.8M · SEC
  • Oct 23, 2026 Guthart Gary S Director Open-market sale · 10b5-1 plan 20,095 shares · $9.1M · SEC
  • Oct 23, 2026 Barratt Craig H Director Open-market sale · 10b5-1 plan 1,150 shares · $510.4K · SEC
  • Oct 23, 2026 Wadors Patricia L Officer Open-market sale · 10b5-1 plan 1,078 shares · $478.4K · SEC
  • Sep 15, 2026 Widman Fredrik Officer Open-market sale · 10b5-1 plan 543 shares · $203.3K · SEC
  • Sep 15, 2026 Widman Fredrik Officer Open-market sale · 10b5-1 plan 546 shares · $204.4K · SEC

Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.

Trend score +25

Price vs. EMA 50+15
Price vs. EMA 200+15
EMA 50 vs. EMA 200-20
ADX (trend strength)+0
Highs and lows+0
Relative strength+15

Volatility and trend strength

ADX 14 (trend strength)15.4
Rel. strength 60 d+17.6%

ATR and moving averages as price values only when logged in.

More stocks from Health Care

All symbols in this sector

News

Latest news

Posts

No posts on ISRG yet – log in to join the discussion.

Posts are opinions of users and only visible after logging in. Community rules

Set alert: ISRG

Alerts with a free account: we send you an email as soon as the price moves above or below your level, reaches the buy zone or the buy zone becomes invalid.

Checked after every data update: crypto hourly (buy zones every 4 hours), stocks twice a day, precious metals every 4 hours on trading days, extended universe weekly – not in real time.

Log in Sign up free

↑ ↓ select · Enter open · Esc close